After Falling 21% in a Month, Is There Any Hope for BioCryst Pharmaceuticals?

After Falling 21% in a Month, Is There Any Hope for BioCryst Pharmaceuticals?

Submitted by admin on April 19, 2022 - 11:00am
Source: 
Motley Fool
News Tags: 
Biocryst
Orladeyo
Rapivab
Headline: 
After Falling 21% in a Month, Is There Any Hope for BioCryst Pharmaceuticals?
snippet: 
  • Some of its clinical trials have recently paused enrollment.
  • Pauses are not uncommon, but they can still rattle shareholders.
  • Current medicines on the market are likely to deliver revenue growth for a while.

Do Not Allow Advertisers to Use My Personal information